-
2022-500237-92-00
5
2021-04-23
Newly-diagnosed high-intermediate and high-risk diffuse large B-cell l
-
2024-514467-26-00
4
2021-04-07
Indolent Systemic Mastocytosis
-
2023-506962-30-00
5
2021-03-29
Non-alcoholic steatohepatitis (NASH)
-
2024-514502-31-00
5
2021-01-11
Prurigo Nodularis
-
2024-512887-77-00
9
2020-10-21
advanced-stage malignancies harboring BRAF mutations with impaired
kin
-
2024-516481-11-00
5
2020-09-22
Metastatic Castration-Resistant Prostate Cancer
-
2024-511832-29-00
4
2020-08-05
High risk adenocarcinoma of the prostate after radical prostatectomy
(
-
2024-516271-32-00
5
2020-06-03
Adenocarcinoma of the gastroesophageal junction (AEG type I-III)
-
2024-511577-29-01
5
2020-03-13
intermediate and high-risk rectal cancer
-
2023-510248-19-00
5
2020-01-21
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
-
2024-512525-83-00
5
2020-01-07
Hypertension
-
2023-506184-34-00
5
2019-08-09
Advanced Malignancies
-
2024-515769-32-00
5
2019-07-02
HR+/HER2- early breast cancer
-
2024-512585-34-00
4
2019-02-27
Indolent Systemic Mastocytosis (ISM)
-
2024-514945-12-00
10
2018-09-03
locally advanced resectable adenocarcinoma of the oesophagogastric
jun
-
2024-515783-31-00
5
2018-08-24
Newly Diagnosed Multiple Myeloma
-
2023-508018-41-00
4
2018-07-27
Primary Myelofibrosis (PMF), Post-polycythemia Vera or Post-essential
-
2023-509856-32-00
5
2018-07-15
acute lymphoblastic leukemia in children and adolescents
-
2024-510913-13-00
10
2018-05-18
Previously Untreated Metastatic or Unresectable Melanoma
-
2024-515499-12-00
5
2017-10-02
Acute lymphoblastic leukemia
-
2023-509425-53-00
5
2015-11-09
Atopic Dermatitis
-
2023-506524-82-00
5
2015-10-21
Stage IB-IIIA non-small cell lung carcinoma, with a centrally confirme
-
2024-515619-23-00
4
2015-06-29
essential thrombocythemia
-
2024-518180-35-00
4
2025-03-03
Hidradenitis Suppurativa